Fischerova D, Planchamp F, Alcázar J L, Dundr P, Epstein E, Felix A, Frühauf F, Garganese G, Salvesen Haldorsen I, Jurkovic D, Kocian R, Lengyel D, Mascilini F, Stepanyan A, Stukan M, Timmerman S, Vanassche T, Ng Z Yuan, Scovazzi U
Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Institut Bergonie, Bordeaux, France.
Int J Gynecol Cancer. 2025 Apr;35(4):101732. doi: 10.1016/j.ijgc.2025.101732. Epub 2025 Mar 21.
The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) with the European Society of Gynaecological Oncology (ESGO) jointly developed clinically relevant and evidence-based statements on performing ultrasound-guided biopsies in gynecological oncology. The objective of this Consensus Statement is to assist clinicians, including gynecological sonographers, gynecological oncologists and radiologists, to achieve the best standards of practice in ultrasound-guided biopsy procedures. ISUOG/ESGO nominated a multidisciplinary international group of 16 experts who have demonstrated leadership in the use of ultrasound-guided biopsy in the clinical management of patients with gynecological cancer. In addition, two early-career gynecological fellows were nominated to participate from the European Network of Young Gynae Oncologists (ENYGO) within ESGO and from ISUOG. The group also included a patient representative from the European Network of Gynaecological Cancer Advocacy Groups. The document is divided into six sections: (1) general recommendations; (2) image-guided biopsy (imaging guidance, sampling methods); (3) indications and contraindications; (4) technique; (5) reporting; and (6) training and quality assurance. To ensure that the statements are evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on this review of the literature. During a conference call, the whole group discussed each preliminary statement, and a first round of voting was carried out. The group achieved consensus on all 46 preliminary statements without the need for revision. These ISUOG/ESGO statements on ultrasound-guided biopsy in gynecological oncology, together with a summary of the evidence supporting each statement, are presented herein. This Consensus Statement is supplemented by detailed narrated videoclips presenting different approaches and indications for ultrasound-guided biopsy, a patient leaflet, and an extended version which includes a detailed review of the evidence.
国际妇产科超声学会（ISUOG）与欧洲妇科肿瘤学会（ESGO）联合制定了关于在妇科肿瘤中进行超声引导下活检的临床相关且基于证据的声明。本共识声明的目的是帮助临床医生，包括妇科超声检查医师、妇科肿瘤学家和放射科医生，在超声引导下活检程序中达到最佳实践标准。ISUOG/ESGO提名了一个由16名专家组成的多学科国际小组，这些专家在妇科癌症患者的临床管理中使用超声引导下活检方面表现出了领导能力。此外，还提名了两名早期职业妇科研究员，分别来自ESGO内的欧洲年轻妇科肿瘤学家网络（ENYGO）和ISUOG。该小组还包括一名来自欧洲妇科癌症倡导团体网络的患者代表。该文件分为六个部分：（1）一般建议；（2）图像引导活检（成像引导、采样方法）；（3）适应症和禁忌症；（4）技术；（5）报告；以及（6）培训和质量保证。为确保声明基于证据，对当前文献进行了审查和严格评估。基于对文献的审查起草了初步声明。在一次电话会议上，整个小组讨论了每一项初步声明，并进行了第一轮投票。该小组对所有46项初步声明达成了共识，无需修订。本文介绍了这些ISUOG/ESGO关于妇科肿瘤中超声引导下活检的声明，以及支持每项声明的证据摘要。本共识声明辅以详细的旁白视频片段，展示了超声引导下活检的不同方法和适应症、一份患者传单，以及一个扩展版本，其中包括对证据的详细审查。
